NEW YORK, Aug. 29, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Signet Jewelers Limited (“Signet”) (NYSE:SIG) between January 7, 2016 and June 3, 2016. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Southern District of New York. To get more information go to:
http://www.zlk.com/pslra/signet-jewelers-limited
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the Class Period defendants issued false and misleading statements and/or failed to disclose that: (1) Signet was experiencing difficulty ensuring the safety of customers’ jewelry while in the custody of Signet’s brands; (2) Signet’s employees at stores under at least one of Signet’s brands (Kay) were swapping customers’ stones for less valuable stones; (3) Signet was experiencing a decrease in customer confidence; (4) Signet had increasing competitive pressures; and (5) consequently, Signet’s financial performance was being negatively impacted.
If you suffered a loss in Signet you have until October 24, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 



